CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study

J Infect Dis. 2022 May 16;225(10):1865-1866. doi: 10.1093/infdis/jiac026.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Chemokine CCL5 / genetics
  • Humans
  • Research
  • SARS-CoV-2

Substances

  • CCL5 protein, human
  • Chemokine CCL5